e-learning
resources
London 2016
Sunday, 04.09.2016
Pharmacological intervention in humans and murine models of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduction of lung cytokines and luminal inflammatory cells in IL-1b deficient mice
Irma Mahmutovic Persson (LUND, Sweden), Irma Mahmutovic Persson, Hamid Akbarshahi, Mandy Menzel, Lena Uller
Source:
International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Session:
Pharmacological intervention in humans and murine models of asthma
Session type:
Thematic Poster
Number:
1100
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Irma Mahmutovic Persson (LUND, Sweden), Irma Mahmutovic Persson, Hamid Akbarshahi, Mandy Menzel, Lena Uller. Reduction of lung cytokines and luminal inflammatory cells in IL-1b deficient mice. Eur Respir J 2016; 48: Suppl. 60, 1100
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Autoimmune induction of a COPD-like inflammatory phenotype in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Increased levels of apoptotic and necrotic markers during asthma exacerbation
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
A new model for analysis of chronic bronchial interleukin-8 expression
Source: International Congress 2016 – Airway response to infection
Year: 2016
Characterization of an endogenous Th17-cell generation during sensitization in the murine lung
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Mouse pathway biology models: Investigating the biology of alternaria alternata induced lung inflammation in the mouse - Role of ILC2 and Th2 cytokines
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Chronic pseudomonas aeruginosa airway infection induces peribronchial lymphoid neogenesis in mice
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Hypoxia induces inflammasome activation and influx of neutrophils and T-cells in the lungs
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Arginase 1 contributes to fibrogenesis in the lungs of silica-challenge mice
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Batf3-dependent dendritic cells control house dust mite-driven Th2 and Th17 response through IL-12 production
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Systemic characterization of macrophage phenotypes in allergic airway inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept